Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells

Immunology

Volumn 115, Issue 3, 2005, Pages 325-336

  Mahnke, Yolanda D ^a,b   Schwendemann, Jochen ^a   Beckhove, Philipp ^a   Schirrmacher, Volker ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

Author keywords

Adoptive immunotherapy; Bone marrow; CD8+ T cell memory; Tumour dormancy

Indexed keywords

BROXURIDINE; CELL ADHESION MOLECULE; GAMMA INTERFERON; HERMES ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW; CELL SURVIVAL; CELL TRANSFER; CONTROLLED STUDY; DOWN REGULATION; EX VIVO STUDY; FEMALE; IMMUNOLOGICAL MEMORY; IMMUNOSTIMULATION; IN VIVO STUDY; LYMPH NODE; LYMPHOCYTE MIGRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; TISSUE SPECIFICITY; TUMOR GROWTH; TUMOR IMMUNITY; TURNOVER TIME; UPREGULATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD44; ANTIGENS, NEOPLASM; BONE MARROW; BROMODEOXYURIDINE; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; FEMALE; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; LAC OPERON; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MICE, NUDE; PERITONEUM; PHENOTYPE; WHOLE-BODY IRRADIATION;

EID: 21244484329     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2005.02163.x     Document Type: Article

References (55)

1. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002; 2:251-62.
2. Esser MT, Marchese RD, Kierstead LS, Tussey LG, Wang F, Chirmule N, Washabaugh MW. Memory T cells and vaccines. Vaccine 2003; 21:419-30.
3. Mahnke YD, Schirrmacher V. Characteristics of a potent tumour vaccine-induced secondary anti-tumour T cell response. Int J Oncol 2004; 24:1427-34.
4. Schirrmacher V. Clinical trials of antitumor vaccination with an autologous tumour cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory. Cancer Immunol Immunother 2005; 54:587-98.
5. Schirrmacher V, Beckhove P, Krüger A et al. Effective immune rejection of advanced metastasized cancer. Int J Oncol 1995; 6:505-21.
6. Dudley ME, Rosenberg SA. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat Rev Cancer 2003; 3:666-75.
7. Oehen S, Waldner H, Kundig TM, Hengartner H, Zinkernagel RM. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J Exp Med 1992; 176:1273-81.
8. McHeyzer-Williams MG, Davis MM. Antigen-specific development of primary and memory T cells in vivo. Science 1995; 268:106-11.
9. Sourdive DJ, Murali-Krishna K, Altman JD et al. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J Exp Med 1998; 188:71-82.
10. Lin MY, Selin LK, Welsh RM. Evolution of the CD8 T-cell repertoire during infections. Microbes Infect 2000; 2:1025-39.
11. Opferman JT, Ober BT, Ashton-Rickardt PG. Linear differentiation of cytotoxic effectors into memory T lymphocytes. Science 1999; 283:1745-8.
12. Ochsenbein AF, Karrer U, Klenerman P et al. A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria. Proc Natl Acad Sci USA 1999; 96:9293-8.
13. Schirrmacher V, Jurianz K, Griesbach A. Intra-pinna induction of specific antitumour immune T-cell functions: effect of ear resection after antigen application. Int J Oncol 1997; 11:227-33.
14. Schirrmacher V, Leidig S, Griesbach A. In situ activation of syngeneic tumour-specific cytotoxic T lymphocytes: intra-pinna immunization followed by restimulation in the peritoneal cavity. Cancer Immunol Immunother 1991; 33:299-306.
15. Mahnke YD, Schirrmacher V. T cell memory to cell-bound antigen. In: Witz IP, ed. 2nd International Conference on Tumour Micro environment; Progression, Therapy and Prevention. Baden, Austria: Monduzzi Editore, 2002:181-3.
16. Mahnke YD, Schirrmacher V. A novel tumour model system for the study of long-term protective immunity and immune T cell memory. Cell Immunol 2003; 221:89-99.
17. Feuerer M, Beckhove P, Garbi N et al. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat Med 2003; 9:1151-7.
18. Khazaie K, Prifti S, Beckhove P, Griesbach A, Russell S, Collins M, Schirrmacher V. Persistence of dormant tumour cells in the bone marrow of tumour cell-vaccinated mice correlates with long-term immunological protection. Proc Natl Acad Sci USA 1994; 91:7430-4.
19. + immune T cells. Cancer Res 1998; 58:5439-46.
20. Carbone FR, Bevan MJ. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med 1990; 171:377-87.
21. Krüger A, Umansky V, Rocha M, Hacker HJ, Schirrmacher V, Von Hoegen P. Pattern and load of spontaneous liver metastasis dependent on host immune status studied with a lacZ transduced lymphoma. Blood 1994; 84:3166-74.
22. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999; 223:77-92.
23. Zal T, Volkmann A, Stockinger B. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J Exp Med 1994; 180:2089-99.
24. Gavin MA, Gilbert MJ, Riddell SR, Greenberg PD, Bevan MJ. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J Immunol 1993; 151:3971-80.
25. Reddehase MJ, Rothbard JB, Koszinowski UH. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 1989; 337:651-3.
26. Jurianz K, Von Hoegen P, Schirrmacher V. Superiority of the ear pinna over a subcutaneous tumour inoculation site for induction of a Th1-type cytokine response. Cancer Immunol Immunother 1998; 45:327-33.
27. Gray D, Matzinger P. T cell memory is short-lived in the absence of antigen. J Exp Med 1991; 174:969-74.
28. Mullbacher A. The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. J Exp Med 1994; 179:317-21.
29. Tanchot C, Lemonnier FA, Perarnau B, Freitas AA, Rocha B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 1997; 276:2057-62.
30. Murali-Krishna K, Lau LL, Sambhara S, Lemonnier F, Altman J, Aimed R. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 1999; 286:1377-81.
31. Swain SL. CD4 T-cell memory can persist in the absence of class II. Philos Trans R Soc Lond B Biol Sci 2000; 355:407-11.
32. Kalams SA, Goulder PJ, Shea AK, Jones NG, Trocha AK, Ogg GS, Walker BD. Levels of human immunodeficiency virus type !-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active anti-retroviral therapy. J Virol 1999; 73:6721-8.
33. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med 1999; 5:518-25.
34. Katayama Y, Hotta H, Nishimura A, Tatsuno Y, Homma M. Detection of measles virus nucleoprotein mRNA in autopsied brain tissues. J Gen Virol 1995; 76(Part 12):3201-4.
35. Panum PL. Observations made during the epidemic of measles on the Faroe Islands in the year 1846. Med Classics 1939; 3:39-868.
36. Van Essen D, Dullforce P, Brocker T, Gray D. Cellular interactions involved in Th cell memory. J Immunol 2000; 165:3640-6.
37. Kelsoe G. Remembrance of things past. Nat Immunol 2000; 1:375-6.
38. Qin D, Wu J, Vora KA, Ravetch JV, Szakal AK, Manser T, Tew JG. Fc gamma receptor IIB on follicular dendritic cells regulates the B cell recall response. J Immunol 2000; 164:6268-75.
39. Schirrmacher V, Zangemeister-Wittke U. γ-irradiation suppresses T cell mediated protective immunity against a metastatic tumour in the afferent phase of the immune response but enhances it in the efferent phase if given before immune cell transfer. Int J Oncol 1994; 4:335-46.
40. Baccala R, Theofilopoulos AN. The new paradigm of T-cell homeostatic proliferation-induced autoimmunity. Trends Immunol 2005; 26:5-8.
41. Alpdogan O, van den Brink MRM. IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol 2005; 26:56-64.
42. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-12.
43. Igietseme JU, Smith K, Simmons A, Rayford PL. Effect of gamma-irradiation on the effector function of T lymphocytes in microbial control. Int J Radiat Biol 1995; 67:557-64.
44. Di Rosa F, Santoni A. Memory T-cell competition for bone marrow seeding. Immunology 2003; 108:296-304.
45. + memory T cells by opposing cytokines. Science 2000; 288:675-8.
46. + T-cell memory. Nat Med 2001; 7:913-9.
47. Feuerer M, Rocha M, Bai L, Umansky V, Solomayer EF, Bastert G, Diel IJ, Schirrmacher V. Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients. Int J Cancer 2001; 92:96-105.
48. Feuerer M, Beckhove P, Bai L et al. Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow. Nat Med 2001; 7:452-8.
49. Feuerer M, Beckhove P, Mahnke Y, Hommel M, Kyewski B, Hamann A, Umansky V, Schirrmacher V. Bone marrow micro-environment facilitating dendritic cell:CD4 T cell interactions and maintenance of CD4 memory. Int J Oncol 2004; 25:867-76.
50. Ohtani O, Cannon B, Ohtsuka A, Murakami T. The microvasculature of bone and especially of bone marrow as studied by scanning electron microscopy of vascular casts - a review. Scanning Electron Microsc 1982; (Part 1):427-34.
51. Di Rosa F, Santoni A. Bone marrow CD8 T cells are in a different activation state than those in lymphoid periphery. Eur J Immunol 2002; 32:1873-80.
52. Akbar AN, Lord JM, Salmon M. IFN-alpha and IFN-beta: a link between immune memory and chronic inflammation. Immunol Today 2000; 21:337-42.
53. Harley CB, Villeponteau B. Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 1995; 5:249-55.
54. Akbar AN, Beverley PC, Salmon M. Will telomere erosion lead to a loss of T-cell memory? Nat Rev Immunol 2004; 4:737-43.
55. Prowse KR, Greider CW. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 1995; 92:4818-22.